Member access

4-Traders Homepage  >  Shares  >  London Stock Exchange  >  GlaxoSmithKline plc    GSK   GB0009252882

GLAXOSMITHKLINE PLC (GSK)

202
SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Income Statement Evolution
Annual Income Statement Data
Actuals in M GBP Estimates in M GBP
Fiscal Period December 201220132014201520162017
Sales26 43126 50523 00624 27325 04025 785
Operating income (EBITDA)9 4158 8838 0457 3727 8788 414
Operating profit (EBIT)8 3308 0156 5946 0466 5336 947
Pre-Tax Profit (EBT)6 6926 6472 9686 0064 7665 089
Net income4 5655 6282 7564 4433 0463 378
EPS (PNC)91,511156,786,162,173,9
Dividend per Share (PNC)74,078,080,086,677,381,5
Yield5,05%5,33%5,46%5,91%5,28%5,57%
Announcement Date02/06/2013
12:01pm
02/05/2014
12:00pm
02/04/2015
03:18pm
---
Finances - Leverage
Actuals in M GBP Estimates in M GBP
Fiscal Period December 201220132014201520162017
Debt14 03712 64514 37712 19012 97413 246
Finance------
Operating income (EBITDA)9 4158 8838 0457 3727 8788 414
Leverage
(Debt/EBITDA)
1,49x1,42x1,79x1,65x1,65x1,57x
Capital Expenditure1 0511 1881 1882 0861 4311 455
Book Value Per Share (BVPS)120 PNC146 PNC87,6 PNC102 PNC111 PNC102 PNC
Cash Flow per Share87,7 PNC149 PNC108 PNC86,4 PNC96,3 PNC107 PNC
Announcement Date02/06/2013
12:01pm
02/05/2014
12:00pm
02/04/2015
03:18pm
---
Balance Sheet Analysis
Assessed data source :
© 2015 Thomson Reuters
Advertisement
Financial Ratios

Size 2015e 2016e
Capitalization 71 266 M GBP -
Entreprise Value (EV) 83 455 M GBP 84 240 M GBP
Valuation 2015e 2016e
PER (Price / EPS) 17,0x 23,6x
Capitalization / Revenue 2,94x 2,85x
EV / Revenue 3,44x 3,36x
EV / EBITDA 11,3x 10,7x
Yield (DPS / Price) 5,91% 5,28%
Price to book (Price / BVPS) 14,3x 13,2x
Profitability 2015e 2016e
Operating Margin (EBIT / Sales) 24,9% 26,1%
operating Leverage (Delta EBIT / Delta Sales) - 2,55x
Net Margin (Net Profit / Revenue) 18,3% 12,2%
ROA (Net Profit / Asset) 13,5% 9,13%
ROE (Net Profit / Equities) 88,2% 101%
Rate of Dividend 101% 125%
Balance Sheet Analysis 2015e 2016e
CAPEX / Sales   8,60% 5,71%
Cash Flow / Sales (Taux d'autofinancement) 17,3% 18,7%
Capital Intensity (Assets / Sales) 1,35x 1,33x
Financial Leverage (Net Debt / EBITDA) 1,65x 1,65x
Price Earning Ratio
EPS & Dividend